Page 213 - The Vasculitides Volumes 2

Peripheral Nerve Vasculitis: Classification and Disease Associations 189

[48] Uchiyama, M., Mitsuhashi, Y., Yamazaki, M., et al. Elderly cases of Churg-Strauss
syndrome: case report and review of Japanese cases. J. Dermatol. 2012; 39:76-79.

[49] Dunogué, B., Pagnoux, C., Guillevin, L. Churg-Strauss syndrome: clinical symptoms,
complementary investigations, prognosis and outcome, and treatment. Semin. Respir.
Crit. Care Med. 2011; 32:298-309.

[50] Hoffman, G. S., Kerr, G. S., Leavitt, R. Y., et al. Wegener granulomatosis: an analysis
of 158 patients. Ann. Intern. Med. 1992;116:488-498.

[51] Holle, J. U., Laudien, M., Gross, W. L. Clinical manifestations and treatment of
Wegener?s granulomatosis. Rheum. Dis. Clin. North Am. 2010; 36:507-526.

[52] Holle, J. U., Gross, W. L., Latza, U., et al. Improved outcome in 445 patients with
Wegener?s granulomatosis in a German vasculitis center over four decades. Arthritis
Rheum. 2011; 63:257-266.

[53] Reinhold-Keller, E., Beuge, N., Latza, U., et al. An interdisciplinary approach to the
care of patients with Wegener?s granulomatosis: long-term outcome in 155 patients.
Arthritis Rheum. 2000; 43:1021-1032.

[54] Collins, M. P., Periquet, M. I. Prevalence of vasculitic neuropathy in Wegener
granulomatosis. Arch. Neurol. 2002; 59:1333-1334.

[55] Suppiah, R., Hadden, R. D. M., Batra, R., et al. Peripheral neuropathy in ANCA-
associated vasculitis: outcomes from the European Vasculitis Study Group trials.
Rheumatology 2011; 50:2214-2222.

[56] Scott, D. G., Bacon, P. A., Tribe, C. R. Systemic rheumatoid vasculitis: a clinical and
laboratory study of 50 cases. Medicine 1981; 60:288-297.

[57] Pavlakis, P. P., Alexopoulos, H., Kosmidis, M. L., et al. Peripheral neuropathies in
Sjögren?s syndrome: a critical update on clinical features and pathogenetic mechanisms.
J. Autoimmun. 2012; 39:27-33.

[58] Rosenbaum, R. Neuromuscular complications of connective tissue diseases. Muscle
Nerve 2001; 24:154-169.

[59] Mori, K., Iijima, M., Koike, H., et al. The wide spectrum of clinical manifestations in
Sjögren?s syndrome-associated neuropathy. Brain 2005; 128:2518-2534.

[60] Pagnoux, C., Cohen, P., Guillevin, L. Vasculitides secondary to infections. Clin. Exp.
Rheumatol. 2006; 24:S71-81.

[61] Lidar, M., Lipschitz, N., Langevitz, P., et al. The infectious etiology of vasculitis.
Autoimmunity. 2009; 42:432-438.

[62] Lenglet, T., Haroche, J., Schnuriger, A., et al. Mononeuropathy multiplex associated
with acute parvovirus B19 infection: characteristics, treatment and outcome. J. Neurol.
2011; 258:1321-1326.

[63] Guillevin, L. Infections in vasculitis. Best Pract. Res. Clin. Rheumatol. 2013; 27:19-31.
[64] Han, S. H. Extrahepatic manifestations of chronic hepatitis B. Clin. Liver Dis. 2004; 8:

403-418.
[65] Khella, S. L., Souayah, N. Hepatitis C: a review of its neurologic complications.

Neurologist 2002; 8:101-106.
[66] Ramos-Casals, M., Stone, J. H., Cid, M. C., et al. The cryoglobulinaemias. Lancet

2012; 379:348-360.
[67] Collins, M. P. The vasculitic neuropathies: an update. Curr. Opin. Neurol. 2012; 25:

573-585.

Complimentary Contributor Copy